In cancer with dyspnea, high-dose dexamethasone did not improve dyspnea and increased SAEs
- PMID: 36592463
- DOI: 10.7326/J22-0106
In cancer with dyspnea, high-dose dexamethasone did not improve dyspnea and increased SAEs
Abstract
Hui D, Puac V, Shelal Z, et al. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial. Lancet Oncol. 2022;23:1321-31. 36087590.
Comment on
-
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.Lancet Oncol. 2022 Oct;23(10):1321-1331. doi: 10.1016/S1470-2045(22)00508-3. Epub 2022 Sep 7. Lancet Oncol. 2022. PMID: 36087590 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical